Inside the Peptide Revolution — What the Science Actually Shows

Clinical Takeaway

Domain	Key Finding	Evidence Level
BPC-157 Human Data	Completed, published human studies: ~14 subjects. Total subjects including canceled, unpublished Phase 1 trial: ~30. Zero RCTs in 30+ years. (See Part II for full evidence scorecard.)	Preclinical only
Statin Safety (CTT 2026)	62 of 66 labeled side effects unsupported in 123,940-person analysis. 90% of symptom burden reproduced by placebo (SAMSON).	Level 1 RCT meta-analysis
BPC-157 Safety Signals	Possible angiogenesis promotion, free radical generation, immune reactions. Two conference-booth injections required ventilation. Cases pending adjudication.	Case reports / preclinical
Regulatory Landscape	FDA 2023: 19 peptides including BPC-157 placed on "do not compound" list. RFK Jr. vows to loosen restrictions. Gray-market imports from China roughly doubled in 2025.	Evolving / uncertain
Legitimate Peptide Science	Insulin and GLP-1 agonists demonstrate the path: decades of rigorous human trials before clinical use. MOTS-c and humanin in early stages.	Strong (approved agents)
Pharmaceutical vs. Supplement	Peptides ≤40 AA are classified as drugs (FD&C Act), not supplements. Injected subcutaneously, they achieve 80–100% bioavailability, bind specific receptors, trigger signaling cascades, and distribute to tissues — including potentially the CNS. The ~40 AA regulatory threshold is administrative, not pharmacological. A 15 AA peptide with angiogenic activity is not safe by virtue of its size.	Critical education gap

❝

This is Part III of a series

Part I covered the regulatory framework — what Category 1 and Category 2 actually mean, what the FDA's phase trial standard requires, and why RFK Jr.'s reclassification announcement changes access but not evidence. Part II scored all 17 peptides against that standard, compound by compound, from FDA-approved down to no human data. This piece takes a different angle: not what the evidence shows, but why patients don't care — and what that means for how we practice.

Inside the Peptide Revolution — What the Science Actually Shows

Reply

Keep Reading

Substance Over Noise

Inside the Peptide Revolution — What the Science Actually Shows

Subscribe to keep reading

Reply

Keep Reading

Substance Over Noise